Search research articles
Contact Us
Filters
Showing results (661-670 of 704) with videos related to
Page
of 71
Sort By:
BMJ Open
|
July 10, 2020
Connectivity guided theta burst transcranial magnetic stimulation versus repetitive transcranial magnetic stimulation for treatment-resistant moderate to severe depression: study protocol for a randomised double-blind controlled trial (BRIGhTMIND)
Richard Morriss, Lucy Webster, Mohamed Abdelghani, et al.
Anesthesia and Analgesia
|
May 8, 2018
World Health Organization-World Federation of Societies of Anaesthesiologists (WHO-WFSA) International Standards for a Safe Practice of Anesthesia
Adrian W Gelb, Wayne W Morriss, Walter Johnson, et al.
JMIR Research Protocols
|
January 20, 2022
Connectivity-Guided Theta Burst Transcranial Magnetic Stimulation Versus Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Moderate to Severe Depression: Magnetic Resonance Imaging Protocol and SARS-CoV-2-Induced Changes for a Randomized Double-blind Controlled Trial
Stefan Pszczolkowski, William J Cottam, Paul M Briley, et al.
Comprehensive Psychiatry
|
April 12, 2024
When a test is more than just a test: Findings from patient interviews and survey in the trial of a technology to measure antidepressant medication response (the PReDicT Trial)
Susan Brown, Cornelia Ploeger, Boliang Guo, et al.
Journal of Medicinal Chemistry
|
March 9, 2011
The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis
Panayiotis A Procopiou, Christopher Browning, Jennifer M Buckley, et al.
Trials
|
November 25, 2017
The effects of using the PReDicT Test to guide the antidepressant treatment of depressed patients: study protocol for a randomised controlled trial
Jonathan Kingslake, Rebecca Dias, Gerard R Dawson, et al.
Journal of Medicinal Chemistry
|
December 7, 2007
4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists
Panayiotis A Procopiou, Rachael A Ancliff, Mark J Bamford, et al.
JAMA Pediatrics
|
June 18, 2014
Surgery and neurodevelopmental outcome of very low-birth-weight infants
Frank H Morriss, Shampa Saha, Edward F Bell, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
February 27, 2021
The clinical effectiveness of using a predictive algorithm to guide antidepressant treatment in primary care (PReDicT): an open-label, randomised controlled trial
Michael Browning, Amy C Bilderbeck, Rebecca Dias, et al.
Trials
|
July 3, 2024
Early vocational rehabilitation and psychological support for trauma patients to improve return to work (the ROWTATE trial): study protocol for an individually randomised controlled multicentre pragmatic trial
Denise Kendrick, Rebecca Lindley, Lauren Blackburn, et al.
Page
of 71
Search research articles
Search
Showing results (661-670 of 704) with videos related to
Sort By:
Page
of 71
BMJ Open
|
July 10, 2020
Connectivity guided theta burst transcranial magnetic stimulation versus repetitive transcranial magnetic stimulation for treatment-resistant moderate to severe depression: study protocol for a randomised double-blind controlled trial (BRIGhTMIND)
Richard Morriss, Lucy Webster, Mohamed Abdelghani, et al.
Anesthesia and Analgesia
|
May 8, 2018
World Health Organization-World Federation of Societies of Anaesthesiologists (WHO-WFSA) International Standards for a Safe Practice of Anesthesia
Adrian W Gelb, Wayne W Morriss, Walter Johnson, et al.
JMIR Research Protocols
|
January 20, 2022
Connectivity-Guided Theta Burst Transcranial Magnetic Stimulation Versus Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Moderate to Severe Depression: Magnetic Resonance Imaging Protocol and SARS-CoV-2-Induced Changes for a Randomized Double-blind Controlled Trial
Stefan Pszczolkowski, William J Cottam, Paul M Briley, et al.
Comprehensive Psychiatry
|
April 12, 2024
When a test is more than just a test: Findings from patient interviews and survey in the trial of a technology to measure antidepressant medication response (the PReDicT Trial)
Susan Brown, Cornelia Ploeger, Boliang Guo, et al.
Journal of Medicinal Chemistry
|
March 9, 2011
The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis
Panayiotis A Procopiou, Christopher Browning, Jennifer M Buckley, et al.
Trials
|
November 25, 2017
The effects of using the PReDicT Test to guide the antidepressant treatment of depressed patients: study protocol for a randomised controlled trial
Jonathan Kingslake, Rebecca Dias, Gerard R Dawson, et al.
Journal of Medicinal Chemistry
|
December 7, 2007
4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists
Panayiotis A Procopiou, Rachael A Ancliff, Mark J Bamford, et al.
JAMA Pediatrics
|
June 18, 2014
Surgery and neurodevelopmental outcome of very low-birth-weight infants
Frank H Morriss, Shampa Saha, Edward F Bell, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
February 27, 2021
The clinical effectiveness of using a predictive algorithm to guide antidepressant treatment in primary care (PReDicT): an open-label, randomised controlled trial
Michael Browning, Amy C Bilderbeck, Rebecca Dias, et al.
Trials
|
July 3, 2024
Early vocational rehabilitation and psychological support for trauma patients to improve return to work (the ROWTATE trial): study protocol for an individually randomised controlled multicentre pragmatic trial
Denise Kendrick, Rebecca Lindley, Lauren Blackburn, et al.
Page
of 71